Cassia Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Cassia Capital Partners's LLY Position: Q1 2026 in Review
Cassia Capital Partners increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $42.6K and bringing the position to 1,608 shares worth $1.48M. The position accounts for 0.76% of the portfolio, ranked #31.
Cassia Capital Partners first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.68M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cassia Capital Partners held 1,608 shares of Eli Lilly worth $1.48M as of Q1 2026.
- Cassia Capital Partners bought 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
- Eli Lilly made up 0.76% of Cassia Capital Partners's portfolio in Q1 2026, its #31 holding.
- Cassia Capital Partners first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
- Cassia Capital Partners's Eli Lilly position peaked at $1.68M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cassia Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.